GoCal80 said:
This is a great day for Cal and for a wonderful person, Jennifer Doudna. She teaches part of the huge biology gateway class, Biology 1A. The other semester there is another Nobel laureate, Randy Schekman, teaching this course. Cal undergrads in the life sciences are therefore very lucky as they will have one rock star scientist or the other teaching them Bio 1A.
The dreaded Bio 1A weeder course! i remember the moment i passed the first midterm, i immediately went to declare for MCB just to lock it in. Randy Schekman was one of my professors when I took it, and I loved it.GoCal80 said:
This is a great day for Cal and for a wonderful person, Jennifer Doudna. She teaches part of the huge biology gateway class, Biology 1A. The other semester there is another Nobel laureate, Randy Schekman, teaching this course. Cal undergrads in the life sciences are therefore very lucky as they will have one rock star scientist or the other teaching them Bio 1A.
GoCal80 said:
I wonder if this Nobel will somehow play into Cal's patent fight with MIT over this technology. It seems that this award, made by a committee of scholars that does a deep study of who made the various contributions before making an award, will settle how it will be seen historically.
This is acknowledged by the campus leadership and so it seems likely that the office of Intellectual Property and Industry Research Alliances (IPIRA) is in for a major overhaul.hanky1 said:
Historically, Cal has not been great at filing IP. Stanford and MIT have been phenomenal. Not so much Cal...I'm not sure why but I think we're starting to wake up to this reality.
MilleniaBear said:
There goes another parking spot. How many parking spots are now allocated for Nobel winners? What happens to the spots of deceased winners? We should at least put a marker there and give the spot to the best prof in that discipline.
I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Quote:
Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights.
GoCal80 said:I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
"Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights."
Today was a win for the good guys!
GoCal80 said:I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
"Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights."
Today was a win for the good guys!
Some in our faculty were worried about the politicking going on for the prize and patent.GoCal80 said:I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
ultulty
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
"Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights."
Today was a win for the good guys!
Bearonthebench said:Some in our faculty were worried about the politicking going on for the prize and patent.GoCal80 said:I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
ultulty
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
"Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights."
Today was a win for the good guys!
I am shocked, absolutely shocked, to hear that there might be politics going on in the field of science!Bearonthebench said:Some in our faculty were worried about the politicking going on for the prize and patent.GoCal80 said:I'm a scientist and was worried about this one because the Swedish Royal Academy can be fickle. There were others people were arguing could be worthy of this prize, as indicated in this MIT publication: https://www.technologyreview.com/2020/10/07/1009601/nobel-prize-chemistry-crispr-gene-editing-doudna-charpentier/Big C said:
ultulty
Usually us non-scientists would have a hard time predicting Nobel Prize winners... but not this time!
"Controversial pick: Nobels can go to up to three people, so the committee's choice to leave the third slot unfilled is likely to generate debate. Those potentially left out of the honor include Virginijus iknys, a Lithuanian biochemist at the University of Vilnius who made similar discoveries. Also snubbed is Feng Zhang of MIT, who was among the first to show CRISPR editing in human cells and who has so far prevailed in a costly dispute with Charpentier and Doudna over CRISPR patent rights."
Today was a win for the good guys!
BearForce2 said:
The patent situation is complicated. Berkeley has many patents on CRISPR, and filed first on applying CRISPR to mammalian cells. The MIT group ponied up for fast tracking their patent application related to human applications (Cal should have done that!) and managed to get it approved first on a highly controversial (i.e bullsh*t) call by the patent office. But Cal has patents on the basic process, so any commercialization has to address those patents too. As Doudna once put it metaphorically, Cal has a patent on tennis balls, while MIT has a patent on tennis balls with one specific color. By the way, much credit goes to the French co-winner with Doudna, Emanuelle Charpentier.hanky1 said:GoCal80 said:
I wonder if this Nobel will somehow play into Cal's patent fight with MIT over this technology. It seems that this award, made by a committee of scholars that does a deep study of who made the various contributions before making an award, will settle how it will be seen historically.
I mentioned this last year in the CRISPR thread, but Cal wins the Nobe Prize but MIT wins the patent fight. Would you rather have a Nobel or a billion dollars?
The innovator for this technique was never in question. The patent is...
....unfortunately I think MIT has the stronger position here.
Historically, Cal has not been great at filing IP. Stanford and MIT have been phenomenal. Not so much Cal...I'm not sure why but I think we're starting to wake up to this reality.
Bearprof said:The patent situation is complicated. Berkeley has many patents on CRISPR, and filed first on applying CRISPR to mammalian cells. The MIT group ponied up for fast tracking their patent application related to human applications (Cal should have done that!) and managed to get it approved first on a highly controversial (i.e bullsh*t) call by the patent office. But Cal has patents on the basic process, so any commercialization has to address those patents too. As Doudna once put it metaphorically, Cal has a patent on tennis balls, while MIT has a patent on tennis balls with one specific color. By the way, much credit goes to the French co-winner with Doudna, Emanuelle Charpentier.hanky1 said:GoCal80 said:
I wonder if this Nobel will somehow play into Cal's patent fight with MIT over this technology. It seems that this award, made by a committee of scholars that does a deep study of who made the various contributions before making an award, will settle how it will be seen historically.
I mentioned this last year in the CRISPR thread, but Cal wins the Nobe Prize but MIT wins the patent fight. Would you rather have a Nobel or a billion dollars?
The innovator for this technique was never in question. The patent is...
....unfortunately I think MIT has the stronger position here.
Historically, Cal has not been great at filing IP. Stanford and MIT have been phenomenal. Not so much Cal...I'm not sure why but I think we're starting to wake up to this reality.
They do. As did I when I used that term. It is just that the fast-tracking by MIT resulted in their patent being considered before UC/Cal's was.GivemTheAxe said:Bearprof said:The patent situation is complicated. Berkeley has many patents on CRISPR, and filed first on applying CRISPR to mammalian cells. The MIT group ponied up for fast tracking their patent application related to human applications (Cal should have done that!) and managed to get it approved first on a highly controversial (i.e bullsh*t) call by the patent office. But Cal has patents on the basic process, so any commercialization has to address those patents too. As Doudna once put it metaphorically, Cal has a patent on tennis balls, while MIT has a patent on tennis balls with one specific color. By the way, much credit goes to the French co-winner with Doudna, Emanuelle Charpentier.hanky1 said:GoCal80 said:
I wonder if this Nobel will somehow play into Cal's patent fight with MIT over this technology. It seems that this award, made by a committee of scholars that does a deep study of who made the various contributions before making an award, will settle how it will be seen historically.
I mentioned this last year in the CRISPR thread, but Cal wins the Nobe Prize but MIT wins the patent fight. Would you rather have a Nobel or a billion dollars?
The innovator for this technique was never in question. The patent is...
....unfortunately I think MIT has the stronger position here.
Historically, Cal has not been great at filing IP. Stanford and MIT have been phenomenal. Not so much Cal...I'm not sure why but I think we're starting to wake up to this reality.
I guess the Patent Office does not consider humans to be mammals.